Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria

被引:87
作者
Proft, Fabian [1 ]
Poddubnyy, Denis [1 ]
机构
[1] Charite Univ Med Berlin, Dept Gastroenterol Infectiol & Rheumatol, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany
关键词
Axial spondyloarthritis; ankylosing spondylitis; ASAS; classification criteria; diagnosis; CHRONIC BACK-PAIN; RADIOGRAPHIC SACROILIITIS PROGRESSION; INTERNATIONAL SOCIETY CRITERIA; DOUBLE-BLIND; PERIPHERAL SPONDYLOARTHRITIS; OBSERVER VARIATION; FOLLOW-UP; MULTICENTER; DIAGNOSIS; EFFICACY;
D O I
10.1177/1759720X18773726
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Development of the Assessment in Spondyloarthritis International Society (ASAS) classification criteria for axial spondyloarthritis (SpA) was one of the major breakthroughs in the field over the past decade. Despite some concerns related to the specificity of the criteria, they stimulated research into the early stage of the disease. This resulted in major advances in the understanding of the course of the disease, revealing predictors of progression, improvement in early diagnosis and treatment in axial SpA. In this review, we summarize the recent developments resulting from the introduction of the ASAS classification criteria for axial SpA and the implications for research and clinical practice.
引用
收藏
页码:129 / 139
页数:11
相关论文
共 81 条
[1]   Distinctions Between Diagnostic and Classification Criteria? [J].
Aggarwal, Rohit ;
Ringold, Sarah ;
Khanna, Dinesh ;
Neogi, Tuhina ;
Johnson, Sindhu R. ;
Miller, Amy ;
Brunner, Hermine I. ;
Ogawa, Rikke ;
Felson, David ;
Ogdie, Alexis ;
Aletaha, Daniel ;
Feldman, Brian M. .
ARTHRITIS CARE & RESEARCH, 2015, 67 (07) :891-897
[2]   ASAS classification criteria for axial spondyloarthritis: time to modify [J].
Akkoc, Nurullah ;
Khan, Muhammad A. .
CLINICAL RHEUMATOLOGY, 2016, 35 (06) :1415-1423
[3]  
AMOR B, 1990, REV RHUM, V57, P85
[4]   Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis [J].
Baeten, Dominique ;
Sieper, Joachim ;
Braun, Juergen ;
Baraliakos, Xenofon ;
Dougados, Maxime ;
Emery, Paul ;
Deodhar, Atul ;
Porter, Brian ;
Martin, Ruvie ;
Andersson, Mats ;
Mpofu, Shephard ;
Richards, Hanno B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (26) :2534-2548
[5]   Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis [J].
Baraliakos, Xenofon ;
Haibel, Hildrun ;
Listing, Joachim ;
Sieper, Joachim ;
Braun, Juergen .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (04) :710-715
[6]   Severity of Baseline Magnetic Resonance Imaging-Evident Sacroiliitis and HLA-B27 Status in Early Inflammatory Back Pain Predict Radiographically Evident Ankylosing Spondylitis at Eight Years [J].
Bennett, A. N. ;
McGonagle, D. ;
O'Connor, P. ;
Hensor, E. M. A. ;
Sivera, F. ;
Coates, L. C. ;
Emery, P. ;
Marzo-Ortega, H. .
ARTHRITIS AND RHEUMATISM, 2008, 58 (11) :3413-3418
[7]   Very early spondyloarthritis:: where the inflammation in the sacroiliac joints starts [J].
Bollow, M ;
Hermann, KGA ;
Biedermann, T ;
Sieper, J ;
Schöntube, M ;
Braun, J .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (11) :1644-1646
[8]   Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis [J].
Brandt, Henning C. ;
Spiller, Inge ;
Song, In-Ho ;
Vahldiek, Janis L. ;
Rudwaleit, Martin ;
Sieper, Joachim .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (11) :1479-1484
[9]   Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis:: a multicentre randomised controlled trial [J].
Braun, J. ;
Zochling, J. ;
Baraliakos, X. ;
Alten, R. ;
Burmester, G. ;
Grasedyck, K. ;
Brandt, J. ;
Haibel, H. ;
Hammer, M. ;
Krause, A. ;
Mielke, F. ;
Tony, H-P ;
Ebner, W. ;
Goemoer, B. ;
Hermann, J. ;
Zeidler, H. ;
Beck, E. ;
Baumgaertner, M. ;
Sieper, J. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (09) :1147-1153
[10]   Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial [J].
Braun, J ;
Brandt, J ;
Listing, J ;
Zink, A ;
Alten, R ;
Golder, W ;
Gromica-Ihle, E ;
Kellner, H ;
Krause, A ;
Schneider, M ;
Sörensen, H ;
Zeidler, H ;
Thriene, W ;
Sieper, J .
LANCET, 2002, 359 (9313) :1187-1193